OTCMKTS:LCDX

Caliber Imaging & Diagnostics (LCDX) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
1,396 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
LCDX stock logo

About Caliber Imaging & Diagnostics Stock (OTCMKTS:LCDX)

Caliber Imaging & Diagnostics, Inc., a medical technologies company, designs, develops, and markets imaging solutions that shows tissue at the cellular level in the United States. The company provides VivaScope 1500, a reflectance confocal imaging system that enables clinicians and researchers to capture confocal images that depict cellular structures of living tissue; and VivaScope 3000, a hand-held in vivo reflectance confocal microscope for skin imaging. It also offers VivaScan software to schedule patients for examinations, perform imaging examinations on one or more lesions during a visit, review, and report on images obtained during an examination, as well as VivaNet, a digital telepathology system. The company was formerly known as Lucid, Inc. and changed its name to Caliber Imaging & Diagnostics, Inc. in August 2012. Caliber Imaging & Diagnostics, Inc. was founded in 1991 and is headquartered in Andover, Massachusetts.

LCDX Stock News Headlines

Caliber Imaging & Diagnostics, Inc. (LCDX)
Caliber Imaging & Diagnostics Inc.
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty.
Caliber Imaging & Diagnostic (LCDX) Gets a Hold from RBC Capital
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty.
Caliber Imaging & Diagnostics Inc (LCDX)
See More Headlines
Receive LCDX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Caliber Imaging & Diagnostics and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
Current Symbol
OTCMKTS:LCDX
CIK
N/A
Fax
N/A
Employees
28
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

  • Mr. William J. Shea (Age 76)
    Executive Chairman
  • Mr. L. Michael Hone (Age 74)
    CEO & Director
    Comp: $350k
  • Mr. William J. Fox (Age 58)
    CTO & VP of Technology Operations
    Comp: $139.16k
  • Ms. Karen Howe
    Chief Financial Officer
  • Mr. Robert T. Kelley
    Vice President of Sales & Marketing

LCDX Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Caliber Imaging & Diagnostics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Caliber Imaging & Diagnostics investors own include Etsy (ETSY), J C Penney (JCP), NVIDIA (NVDA), Tesla (TSLA), Alibaba Group (BABA), Youdao (DAO), Advanced Micro Devices (AMD), Costco Wholesale (COST), International Business Machines (IBM) and Netflix (NFLX).

How do I buy shares of Caliber Imaging & Diagnostics?

Shares of LCDX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:LCDX) was last updated on 5/6/2024 by MarketBeat.com Staff

From Our Partners